Golden
AbbVie Biotech Ventures

AbbVie Biotech Ventures

AbbVie Biotech Ventures, an Illinois-based company, makes investments in emerging biotech and pharmaceutical companies.

AbbVie Biotech Ventures - also known as AbbVie Ventures - is a venture capital firm based in North Chicago, Illinois. The firm was founded in 2009, and it is a subsidiary of AbbVie. AbbVie itself was a business operation of Abbott Laboratories until 2013 when it became a separate company. As of October 2019, the firm has invested in 47 companies and maintains its ownership on 25 active companies.



Abbie Biotech Ventures focuses on investing in companies developing solutions in the fields of oncology, immunology, and neuroscience. The firm focuses on providing capital for eight companies each year. It prefers to invest in companies at the seed or series A stage.

Timeline

Funded Companies

7 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

Rheostat, located at 300 Technology Square, in Cambridge, Massachusetts is a biotech company developing treatments for neurodegenerative diseases by targeting mitophagy and autophagy pathways.

Rodeo Therapeutics is a preclinical-stage biotech company focused on first in class small molecule modulators of prostaglandin biology for enhancing tissue repair and regeneration.

Artios Pharma develops cancer treatments that target DNA Damage Response (DDR) Pathways to selectively kill cancer cells

Alector is a San Francisco-based company.

ApoGen Biotechnologies is a Seattle-based company.

Quentis Therapeutics is a New York City-based company.

Palleon Pharmaceuticals is a Waltham, Massachusetts-based company.

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References